event date
Thursday, June 24, 2021 15:00
This presentation is about Televend, a new digital medicine distribution method that combines a darknet backend with a shopbot messaging app frontend.
In 2011, the first darknet market for illegal drugs, the crypto market (Silk Road), began trading. This is a significant innovation in the digitally mediated drug trade, allowing buyers to use anonymized browsers and currencies to purchase illegal drugs from a set of vendors with high quality rankings. Completing purchases on darknet markets requires a high degree of technical expertise. Many are deterred by these requirements and instead stick to face-to-face interactions or utilize other digital intermediary channels such as social media and messaging apps that lack the security and quality checking features of the crypto market. I am. Televend is a new hybrid format digital marketplace. Televend describes itself as a “direct trading platform that uses Telegram bots to interact with customers through an in-app storefront and a Tor-based .onion vendor panel for vendors to fully automate order and customer management.” explains. Based on the Global Drug Survey's Observations and Expertise module (data collected from December 2020 to March 2021), Monica Barratt will answer the following questions in this presentation: How does Televend work? Who is using Televend and how is it being used compared to other procurement methods? Televend users are choosing to use Televend in comparison to darknet markets and social media/crypto, based on risks and benefits. How does it compare to app trading?
About the speaker
Dr Monica Barratt is a drug policy researcher at RMIT University's Center for Social and Global Research and the Center for Digital Ethnography, and holds a part-time role at UNSW's National Center for Drug and Alcohol Research. Monica researches digitally facilitated drug trade, emerging psychoactive substance trends and markets, drug testing and pill testing, and ways to increase the meaningful involvement of drug users in research and policy processes. Monica He has published over 80 academic research papers and he has attracted over $4 million in competitive grants from including NHMRC and his NIH. She has led research at Bluelight.org, Global Drug Survey and The Loop Australia, and is an editor for the leading pharmaceutical journals, International Journal of Drug Policy and Drug and Alcohol Review.
position
This is an online event. Once you register, you will receive a link via email.
Fee
free
contact
NDARC.events@unsw.edu.au
